{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:33:09Z","timestamp":1768289589380,"version":"3.49.0"},"reference-count":14,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Janssen-Cilag Australia"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2023,1,28]]},"DOI":"10.1080\/10428194.2022.2148220","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:03:15Z","timestamp":1669305795000},"page":"312-318","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program"],"prefix":"10.1080","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1928-2098","authenticated-orcid":false,"given":"Stephen P.","family":"Mulligan","sequence":"first","affiliation":[{"name":"Department of Haematology, Royal North Shore Hospital","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0308-6458","authenticated-orcid":false,"given":"Stephen","family":"Opat","sequence":"additional","affiliation":[{"name":"Monash Health, Monash University","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7988-1565","authenticated-orcid":false,"given":"Chan Y.","family":"Cheah","sequence":"additional","affiliation":[{"name":"Department of Haematology, Sir Charles Gairdner Hospital","place":["Perth, Australia"]},{"name":"Department of Haematology, Pathwest Laboratory Medicine","place":["Perth, Australia"]},{"name":"School of Medicine, University of Western Australia","place":["Perth, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryone","family":"Kuss","sequence":"additional","affiliation":[{"name":"Flinders Medical Centre and Finders University","place":["Bedford Park, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hertzberg","sequence":"additional","affiliation":[{"name":"Department of Haematology, Prince of Wales Hospital","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Marlton","sequence":"additional","affiliation":[{"name":"Department of Haematology, Princess Alexandra Hospital","place":["Brisbane, Australia"]},{"name":"University of Queensland School of Medicine","place":["Brisbane, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Poplar","sequence":"additional","affiliation":[{"name":"Northland Cancer and Blood Services, Northland District Health Board","place":["Whangarei, New Zealand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Puig","sequence":"additional","affiliation":[{"name":"Real-world Evidence, Janssen-Cilag Pty Ltd","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"McGeachie","sequence":"additional","affiliation":[{"name":"Medical and Scientific Affairs, Janssen-Cilag Pty Ltd","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-7988","authenticated-orcid":false,"given":"Robert","family":"Weinkove","sequence":"additional","affiliation":[{"name":"Te Rerenga Ora Blood & Cancer Centre, Wellington Hospital","place":["Wellington, New Zealand"]},{"name":"Cancer Immunotherapy Programme, Malaghan Institute of Medical Research","place":["Wellington, New Zealand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine S.","family":"Tam","sequence":"additional","affiliation":[{"name":"Alfred Hospital and Monash University","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"Therapeutic Goods Administration. Australian product information; IMBRUVICA\u00ae Ibrutinib capsules and tablets. Therapeutic Goods Administration; Canberra ACT Australia; 2021."},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.175"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.192328"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00667-4"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006434"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000712"},{"key":"e_1_3_5_9_1","unstructured":"Medsafe. IMBRUVICA\u00ae ibrutinib New Zealand Data Sheet. Medsafe; Wellington New Zealand; 2021."},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1157\/13119325"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000566072.14397.15"},{"key":"e_1_3_5_12_1","unstructured":"Hertzberg M Cheah CY Tam C et\u00a0al. Real-world experience of Australian and New Zealand relapsed or refractory mantle cell lymphoma patients on ibrutinib in a Named Patient Program. Haematology Society of Australia and New Zealand Annual Scientific Meeting. Blood. 2018. P070"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0805-y"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18306"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2022.2148220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:26:16Z","timestamp":1757924776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2022.2148220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1,28]]}},"alternative-id":["10.1080\/10428194.2022.2148220"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2022.2148220","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}